ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,038,047 | -35.2% | 383,813 | +16.3% | 0.00% | 0.0% |
| Q2 2023 | $3,144,347 | -5.5% | 329,942 | +9.1% | 0.00% | 0.0% |
| Q1 2023 | $3,327,522 | -25.5% | 302,502 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $4,465,574 | -19.7% | 301,728 | +3.7% | 0.00% | -50.0% |
| Q3 2022 | $5,563,000 | +20.2% | 291,093 | +34.0% | 0.00% | 0.0% |
| Q2 2022 | $4,630,000 | +19.6% | 217,260 | +8.1% | 0.00% | +100.0% |
| Q1 2022 | $3,871,000 | -6.0% | 200,964 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $4,116,000 | -12.0% | 198,453 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $4,679,000 | -11.3% | 195,837 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $5,278,000 | +1.5% | 193,382 | +7.6% | 0.00% | 0.0% |
| Q1 2021 | $5,199,000 | +30.7% | 179,680 | +27.0% | 0.00% | 0.0% |
| Q4 2020 | $3,979,000 | +22.7% | 141,439 | +27.9% | 0.00% | +100.0% |
| Q3 2020 | $3,242,000 | +57.1% | 110,623 | +62.1% | 0.00% | 0.0% |
| Q2 2020 | $2,064,000 | +214.2% | 68,246 | +209.9% | 0.00% | – |
| Q1 2020 | $657,000 | – | 22,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |